Lonza Group AG (SWX: LONN) Stock Analysis & Fundamentals | ScreenerHero

Create free account

LONNLonza Group AG

SWX · CH · Healthcare · Diagnostics & Research · lonza.com

574.20CHF+1.70%Mkt Cap: 45.77B $P/E: 44.201d ago

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Pricier

P/B

Avg

Div Yield

Higher

1M Perf

Lower

Thermo Fisher Scientific Inc.

$194.52BUSDP/E 28.7

Danaher Corporation

$140.09BUSDP/E 38.3

IDEXX Laboratories, Inc.

$44.00BUSDP/E 41.0

Waters Corporation

$37.24BUSDP/E 48.3

Agilent Technologies, Inc.

$36.91BUSDP/E 26.2

IQVIA Holdings Inc.

$34.55BUSDP/E 25.7

$28.55BUSDP/E 34.4

Mettler-Toledo International Inc.

$26.44BUSDP/E 30.8

Quest Diagnostics Incorporated

$23.88BUSDP/E 23.8

Labcorp Holdings Inc.

$23.53BUSDP/E 25.4

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.92BUSDP/E 35.1

Eurofins Scientific SE

$13.05BUSDP/E 27.2

$12.69BUSDP/E 54.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.90BUSDP/E 20.8

Twist Bioscience Corporation

BillionToOne, Inc.

$5.54BUSDP/E 222.9

Sotera Health Company

$5.11BUSDP/E 43.7

$4.55BUSDP/E 52.9

DiaSorin S.p.A.

$3.76BUSDP/E 26.4

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.53BUSDP/E 38.8

Diagnostyka S.A.

$1.55BUSDP/E 23.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.03BUSDP/E 21.7

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$305.89MUSDP/E 3.1

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.1

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.08MUSDP/E 63.3

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

bioAffinity Technologies, Inc.

Avricore Health Inc.

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap45.77B $

Enterprise Value48.09B $

Revenue (TTM)7.45B $

Gross Profit2.64B $

Net Income (TTM)-313.86M $

Revenue/Share106.45 USD

Last Price574.20 CHF

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees20.0K

CountryCH

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)44.20

P/E (Forward)25.01

PEG1.57

EV/EBITDA19.72

EV/Revenue6.45

P/S5.84

P/B4.82

EPS (TTM)13.00

EPS (Forward)21.82

52W Range

454.6085% of range594.80

52W High594.80 CHF

52W Low454.60 CHF

Profitability

Gross Margin35.35%

Oper. Margin21.39%

EBITDA Margin32.72%

Profit Margin-4.21%

ROE-3.48%

ROA-1.54%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF1.32B $

CapEx (TTM)1.57B $

FCF Margin-27.54%

FCF Yield-4.49%

Net Debt4.52B $

Net Debt/EBITDA1.85

Balance Sheet

Debt/Equity0.57

Current Ratio1.89

Quick Ratio0.62

Book Value/Sh113.30 CHF

Cash/Share10.29 CHF

Dividends

Fwd Div Rate5.000 CHF

Trail. Div Rate5.000 CHF

Div. Yield0.93%

5Y Avg Yield0.67%

Payout Ratio30.77%

Ex-Div DateMay 12, 2026

Pay DateMay 15, 2025

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)665.48 CHF

Upside (mean)+15.9%

Target Range550.00 CHF – 815.00 CHF

CHF550.00+15.9% to meanCHF815.00

# Analysts23

Ownership

Shares Out.69.84M

Float69.81M

Insiders0.09%

Institutions61.38%

Technical

SMA 50494.61 (+16.1%)

SMA 200521.97 (+10.0%)

Beta0.83

S&P 52W Chg20.05%

Avg Vol (30d)153.42K

Avg Vol (10d)173.35K

Technical Indicators

RSI (14)82.9

MACD18.2718

MACD Signal10.7348

MACD Hist.+7.5370

BB Upper572.15 CHF

BB Middle514.37 CHF

BB Lower456.60 CHF

BB Width22.47%

ATR (14)12.22 CHF

Vol Ratio (20d)1.05x